Information Library
White Papers - Faster product development
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
Rebalancing Risk to Transform R&D
June 3, 2009
A strategic approach to re-balancing the main components of biopharma company risk: portfolio, operational and resource. -
Reinventing the Clinical Trial
March 31, 2009
As a new era of drug discovery unfolds, reinventing the clinical trial is essential to medical advancement. -
Monitoring for Quality
May 22, 2008
Scott Cooley, Executive Director, Phase IIIb/IV Product Management, Quintiles, discusses innovative and traditional resources in a risk-based monitoring program.
Page 1 of 1 (3 items)